Stephen Hanessian
University of California, USA
Keynote: Med chem
Monumental achievements in drug development within the pharmaceutical industry worldwide have benefitted humankind with improving our quality of life and providing life-saving medicines over decades of dedicated work. Academic research has also been instrumental in making fundamental contributions at the interface between the chemical, physical and biological sciences, and especially in the training of future scientists who eventually contribute to the invention of new medicines. Indeed some of the most important insights into our understanding of basic chemical and biological processes at the molecular level continue to come from academic groups. The lecture will cover various aspects of our research projects in the area of structure-based organic synthesis towards novel drug prototypes emphasizing a biology-inspired, chemistry driven approach and highlighting examples of highly successful collaborative projects with a plethora of research groups in various pharmaceutical companies without compromising the sanctity of basic research principles and the noble objective of coworker training in an academic setting.
Stephen Hanessian holds the Ionis Pharmaceutical Research Chair at the Université de Montréal. He is also the Faculty in the Departement of Pharmaceutical Sciences, University of California, Irvine as the Director of the Medicinal Chemistry and Pharmacology Graduate Program. His research interests are in organic, bioorganic and medicinal chemistry with nearly 550 original publications and several patents to his credit. His recent books “Design and Strategy in Organic Synthesis” Wiley-VCH, 2013, and “Natural Products in Medicinal Chemistry” Wiley-VCH, 2014, are widely acclaimed monographs.
Medicinal Chemistry received 6627 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 